X-energy and Yesway Show Strong Debut Performance
X-energy and Yesway have both made their public debuts last week after pricing. The launches highlighted continued investor appetite across both energy innovation and everyday retail.LATEST IPOS AND DIRECT LISTINGS:X-energyopened on April 24 at $30.11. The developer of advanced small modular nuclear reactors and fuel technology for clean energy generation priced 44.25M shares at $23.00. The deal size was increased to 44.25M shares from 42.86M and priced above the $16.00-$19.00 target range.Elmetopened on April 23 at $18. The company priced 8.6M shares at $14.00 per share. The deal size was increased to 8.6M shares of common stock from 7.7M shares and priced at the high-end of the $12.00-$14.00 range. Elmet is a U.S.-based provider of precision-engineered components and advanced high-energy systems for the Aerospace, Defense and Government, Industrial, Medical, Semiconductor and Electronics, and Energy industries.Yeswayopened on April 22. The company had priced its IPO at $20 per share. Yesway is a U.S.-based convenience store operator that operates primarily under two brands, Yesway and Allsup's.National Healthcare Propertiesopened on April 22 at $11.56. The company priced 38.5M shares of its Class A common stock at $12.00 per share. National Healthcare Properties is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on senior housing and outpatient medical facilities located in the United States.Liberty Defenseopened on April 22. The company priced 3.67M shares at $4.50, the midpoint of its $4.00-$5.00 range. Liberty Defense provides multi-technology security solutions for concealed weapons detection in high volume foot traffic areas and locations requiring enhanced security such as airports, stadiums and schools.PERFORMANCE:Prices as of 11 am ET on Monday, April 27X-energy – up almost 15% at $33.57;Elmet – down about 3% at $16.57;Yesway – fractionally down at $21.64;National Healthcare Properties – fractionally up at $12.89;Liberty Defense – up almost 1% at $4.65.RECENT IPOS TO WATCH:HMH Holdingis already seeing coverage roll out, while KPET Ultra Pacelineis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include Tarsier Pharma, Quantinuum, Cerebras, Boundless Group, and Liftoff.Clickto see upcoming IPO calendar on TipRanks.Tarsier Pharma Ltd.filed for an initial public offering of its ordinary shares and applied to list its ordinary shares on the NYSE American under the symbol "TARX". The prospectus stated: "Tarsier Pharma is developing TRS01 and TRS02, novel product candidates based on dazdotuftide, a new molecule with a new mechanism of action for uveitis and uveitic glaucoma. We are attempting to address a significant, underserved market opportunity and have engaged closely with the FDA on our clinical development strategy, including a Special Protocol Assessment agreement for our planned pivotal trial... Although we are still early in this journey, I believe we have the technology, the team, the discipline, and the persistence required to build an enduring company."Honeywellannounced thatQuantinuum, which is majority owned by Honeywell, confidentially submitted a draft registration statement on Form S-1 to the U.S. SEC on February 17, relating to the proposed initial public offering of Quantinuum's common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.Cerebras Systemsannounced that it has filed a registration statement on Form S-1 with the U.S. SEC relating to a proposed initial public offering of its Class A common stock. The number of shares of Class A common stock to be offered and the price range for the proposed offering have not yet been determined. Cerebras intends to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol "CBRS." Morgan Stanley, Citigroup, Barclays, and UBS Investment Bank will act as lead book-running managers for the proposed offering. Mizuho and TD Cowen will act as bookrunners. Needham & Company, Craig-Hallum, Wedbush Securities, Rosenblatt, and Academy Securities will act as co-managers.Boundless Groupis offering 4M Class A ordinary shares on a firm commitment basis in an initial public offering. The company expects the initial public offering price of its Class A ordinary shares to be in the range of $4.00 to $5.00 per share.Liftoff Mobileannounced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The total number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.OTHER IPO NEWS:Amesiteannounced that it has filed with the U.S. SEC a request for withdrawal of the company's Registration Statement on Form S-1 originally filed on April 20, as the company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the public offering described in the Registration Statement.Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.
Trade with 70% Backtested Accuracy
Analyst Views on XE
About XE
About the author

- IPO Plans: Deep Fission filed for an initial public offering on Wednesday, intending to offer 6 million shares on the Nasdaq Global Market at an estimated price range of $24 to $26 per share, potentially valuing the company at approximately $1.65 billion.
- Innovative Nuclear Technology: The startup is pursuing a novel approach by placing reactors deep underground, which aims to reduce construction costs and enhance safety compared to traditional above-ground nuclear facilities, potentially attracting more investor interest.
- Strong Market Demand: As electricity demand surges from artificial intelligence and data centers, investor appetite for nuclear startups remains robust, with Deep Fission's filing indicating a growing willingness among public investors to fund early-stage nuclear technology despite regulatory hurdles and capital requirements.
- Industry Recovery Signal: Following X-Energy's successful IPO, the nuclear startup IPO market is gradually reviving, and Deep Fission's filing may further encourage institutional investors to support nuclear projects through traditional IPOs, fostering industry growth.
- IPO Valuation Target: Deep Fission aims for a valuation of approximately $1.66 billion in its U.S. IPO, seeking to capitalize on surging investor demand for nuclear power, particularly as AI-driven electricity consumption rises.
- Funding Size and Pricing: The company plans to raise up to $156 million by offering 6 million shares priced between $24 and $26 each, which will support the development of its small modular reactor technology.
- Market Demand Revival: With renewed interest in nuclear energy driven by data centers and AI applications, Deep Fission's IPO comes at a pivotal moment for nuclear developers, indicating a shift in public sentiment towards nuclear power.
- Technological Innovation and Policy Support: The company is developing a small modular reactor called the Gravity Reactor, leveraging established pressurized water reactor technology, and is benefiting from a series of executive orders from the Trump administration aimed at boosting domestic energy capacity and accelerating SMR deployment.
- Coverage Initiation: Guggenheim has initiated coverage of X-Energy with a 'Buy' rating and a $57 price target, indicating an upside of approximately 112.85% from its last closing price, reflecting the analyst's recognition of the company's leadership in next-generation nuclear technology.
- Market Attention: Despite X-Energy's stock price declining over 8% since its IPO, Wall Street's interest remains high, with at least eight analysts covering the company and price targets ranging from $28 to $41, demonstrating confidence in its long-term potential.
- Capital Efficiency: Guggenheim highlighted X-Energy's industry-leading contracted backlog and proprietary TRISO-X fuel technology, which is meltdown-proof, along with a capital-efficient licensing model that generates revenue without owning or operating facilities, enhancing the attractiveness of its business model.
- Amazon Support: Amazon owns about 20% of X-Energy and has invested $500 million to support the advancement of over 5 GW of new nuclear capacity in the U.S. by 2039, providing a solid foundation for X-Energy's future growth through strong capital backing.
- Successful IPO: X-Energy raised nearly $1.02 billion by pricing over 44.25 million shares at $23 each during its Nasdaq debut, valuing the company at approximately $9.1 billion, reflecting strong market enthusiasm for nuclear energy and AI-driven electricity demand.
- Bullish Analyst Ratings: Guggenheim, TD Cowen, and UBS initiated coverage with Buy ratings and price targets of $57, $35, and $40 respectively, indicating confidence in X-Energy's future growth potential.
- Growing Market Demand: As major tech companies seek long-term electricity supplies to support AI infrastructure, X-Energy's small modular reactor (SMR) technology is positioned as a lower-cost and safer alternative to traditional nuclear plants, likely attracting more investor interest.
- Strategic Partnerships: X-Energy has secured agreements with companies like Amazon, Dow, and Centrica, showcasing strong backing in advanced nuclear development and further solidifying its market position.
- Micron Price Target Increase: Citigroup raised Micron Technology's price target from $425 to $840, anticipating a 40% increase in DRAM prices in Q2, which will significantly enhance its market competitiveness.
- Jazz Pharmaceuticals Upgrade: UBS upgraded Jazz Pharmaceuticals from Neutral to Buy and raised its price target from $188 to $307, driven by increased confidence in the commercial potential of its cancer drug Ziihera, which is expected to boost company performance.
- Nvidia Price Target Boost: HSBC raised Nvidia's price target from $295 to $325, expecting the company to exceed market expectations in its upcoming earnings report, further enhancing its profitability.
- Costco Price Target Increase: Oppenheimer raised Costco's price target from $1,100 to $1,160, believing that its defensive characteristics and superior value proposition will continue to drive market share growth, with potential catalysts for a special dividend or stock split.
- Environmental Assessment Completed: The U.S. Nuclear Regulatory Commission has finalized its environmental assessment for Dow Inc. (DOW) and X-energy's (XE) construction permit application for an advanced nuclear project in Texas, confirming no significant impact, marking a key milestone for the project.
- Review Ahead of Schedule: The review was completed ahead of schedule, indicating strong regulatory support for the project, which may expedite subsequent construction processes and enhance investor confidence.
- Independent Analysis Validated: The NRC's assessment was based on extensive independent analysis of air quality, water resources, and local species habitats, adhering to globally recognized safety and environmental standards, ensuring the project's sustainability.
- Industrial Application Potential: The proposed Long Mott Generating Station will provide electricity and high-temperature industrial steam to Dow's UCC Seadrift Operations, expected to produce over 4 billion pounds of materials annually, becoming North America's first grid-scale advanced nuclear reactor serving an industrial site.











